ClinicalTrials.Veeva

Menu

Effects of Prostate Cancer on Brain Function

T

Tongji University

Status

Enrolling

Conditions

Prostate Cancer

Treatments

Diagnostic Test: functional magnetic resonance imaging examination、Zung Self Rating Anxiety Scale and Beck Depression Inventory-II

Study type

Observational

Funder types

Other

Identifiers

NCT05737004
EF2023-01

Details and patient eligibility

About

To explore whether the patients with prostate cancer have functional changes in specific brain areas and changes in psychological and mental characteristics compared with the patients without prostate cancer.

Full description

This study was intended to observe the functional changes of brain fMRI in patients with and without prostate cancer enrolled in the cohort of patients who planned to undergo prostate biopsy, in an attempt to discover specific brain region changes in patients with prostate cancer, and lay a foundation for further clarifying the relationship and mechanism between brain region function changes and prostate cancer.

Enrollment

250 estimated patients

Sex

Male

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Between the ages of 18 and 80
  2. Patients with prostate biopsy;
  3. No history of other malignant tumors;
  4. Exclude other malignant tumors;
  5. Fully understand the clinical trial protocol and sign informed consent;

Exclusion criteria

  1. magnetic resonance contraindications;
  2. symptomatic acute or chronic inflammation of the prostate;
  3. Patients with brain trauma or brain disease;
  4. Patients who have died of other malignancies in the past or are currently suffering from other malignancies;
  5. Patients judged by the investigator to be unfit to participate in the clinical trial;

Trial design

250 participants in 2 patient groups

Prostate cancer group
Description:
Prostate cancer was confirmed by biopsy, and fMRI examination 、Zung Self Rating Anxiety Scale and Beck Depression Inventory-II were performed in these patients within 1 week before biopsy .
Treatment:
Diagnostic Test: functional magnetic resonance imaging examination、Zung Self Rating Anxiety Scale and Beck Depression Inventory-II
Non-Prostate cancer group
Description:
Non-Prostate cancer was confirmed by biopsy, and fMRI examination 、 Zung Self Rating Anxiety Scale and Beck Depression Inventory-II were performed in these patients within 1 week before biopsy .
Treatment:
Diagnostic Test: functional magnetic resonance imaging examination、Zung Self Rating Anxiety Scale and Beck Depression Inventory-II

Trial contacts and locations

1

Loading...

Central trial contact

Haifeng Wang; Shuaidong Wang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems